Literature DB >> 19512902

Evaluation of a new tear osmometer for repeatability and accuracy, using 0.5-microL (500-Nanoliter) samples.

Elvin H Yildiz1, Vincent C Fan, Hina Banday, Lakshmi V Ramanathan, Ratna K Bitra, Eileen Garry, Penny A Asbell.   

Abstract

PURPOSE: To evaluate the repeatability and accuracy of a new tear osmometer that measures the osmolality of 0.5-microL (500-nanoliter) samples.
METHODS: Four standardized solutions were tested with 0.5-microL (500-nanoliter) samples for repeatability of measurements and comparability to standardized technique. Two known standard salt solutions (290 mOsm/kg H2O, 304 mOsm/kg H2O), a normal artificial tear matrix sample (306 mOsm/kg H2O), and an abnormal artificial tear matrix sample (336 mOsm/kg H2O) were repeatedly tested (n = 20 each) for osmolality with use of the Advanced Instruments Model 3100 Tear Osmometer (0.5-microL [500-nanoliter] sample size) and the FDA-approved Advanced Instruments Model 3D2 Clinical Osmometer (250-microL sample size).
RESULTS: Four standard solutions were used, with osmolality values of 290, 304, 306, and 336 mOsm/kg H2O. The respective precision data, including the mean and standard deviation, were: 291.8 +/- 4.4, 305.6 +/- 2.4, 305.1 +/- 2.3, and 336.4 +/- 2.2 mOsm/kg H2O. The percent recoveries for the 290 mOsm/kg H2O standard solution, the 304 mOsm/kg H2O reference solution, the normal value-assigned 306 mOsm/kg H2O sample, and the abnormal value-assigned 336 mOsm/kg H2O sample were 100.3, 100.2, 99.8, and 100.3 mOsm/kg H2O, respectively.
CONCLUSIONS: The repeatability data are in accordance with data obtained on clinical osmometers with use of larger sample sizes. All 4 samples tested on the tear osmometer have osmolality values that correlate well to the clinical instrument method. The tear osmometer is a suitable instrument for testing the osmolality of microliter-sized samples, such as tears, and therefore may be useful in diagnosing, monitoring, and classifying tear abnormalities such as the severity of dry eye disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19512902     DOI: 10.1097/ICO.0b013e318198396b

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  5 in total

1.  The Guanine Nucleotide Exchange Factor Brx: A Link between Osmotic Stress, Inflammation and Organ Physiology and Pathophysiology.

Authors:  Tomoshige Kino; James H Segars; George P Chrousos
Journal:  Expert Rev Endocrinol Metab       Date:  2010-07-01

2.  New testing options for diagnosing and grading dry eye disease.

Authors:  Gary N Foulks; Stephen C Pflugfelder
Journal:  Am J Ophthalmol       Date:  2014-03-12       Impact factor: 5.258

3.  [Meibomian glands : part III. Dysfunction - argument for a discrete disease entity and as an important cause of dry eye].

Authors:  E Knop; N Knop; H Brewitt; U Pleyer; P Rieck; B Seitz; F Schirra
Journal:  Ophthalmologe       Date:  2009-11       Impact factor: 1.059

4.  Topical cyclosporine a for treatment of dry eye due to chronic mustard gas injury.

Authors:  Khosrow Jadidi; Yunes Panahi; Ali Ebrahimi; Mostafa Mafi; Farhad Nejat; Amirhossein Sahebkar
Journal:  J Ophthalmic Vis Res       Date:  2014 Oct-Dec

Review 5.  The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical Research.

Authors:  Neeta S Roy; Yi Wei; Eric Kuklinski; Penny A Asbell
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-05-01       Impact factor: 4.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.